Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis
Ludwig Kappos(Novartis (Switzerland)), Massimo Filippi(Vita-Salute San Raffaele University), Andreas Schoetzau(Kantonsspital Baselland), Claudio Gasperini(Nini Hospital), David Moeri(Kantonsspital Baselland), Kati Schweikert(Kantonsspital Baselland), Frederik Barkhof(Netherlands Institute for Neuroscience), Howard L. Weiner(Brigham and Women's Hospital), Charles R.G. Guttmann(Massachusetts General Hospital), Ernst W. Radue(University Hospital of Basel), David Miller
Cited by 500
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k